# Post-transplant-cyclophosphamide plus everolimus as GvHD prophylaxis in refractory T- and B-cell lymphoma

**Authors:** Tim Richardson, Hishan Tharmaseelan, Lukas Frenzel, Philipp Gödel, Moritz Fürstenau, Pascal Nieper, Till Braun, Daniel Schütte, Michael Hallek, Christof Scheid, Udo Holtick

PMC · DOI: 10.1038/s41409-024-02472-3 · Bone Marrow Transplantation · 2024-11-15

## Full-text entities

- **Diseases:** T- and B-cell lymphoma (MESH:D016393), GvHD (MESH:D006086)
- **Chemicals:** cyclophosphamide (MESH:D003520), everolimus (MESH:D000068338)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11810763/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC11810763/full.md

## References

1 references — full list in the complete paper: https://tomesphere.com/paper/PMC11810763/full.md

---
Source: https://tomesphere.com/paper/PMC11810763